A New Miracle Drug: Campaigning for the Introduction of PrEP in Ireland

University Observer: With HIV figures increasing both at home and abroad, David Monaghan looks at the student-led ‘UCD for PrEP’ campaign and how effective the drug is in combating the disease.

 

RISING figures of HIV in Ireland have encouraged student activists to campaign for help in minimising its continued spread. ‘UCD for PrEP’ is a student-led initiative that aims to lobby the Students’ Union to take a proactive stance on introducing the drug ‘pre-exposure prophylaxis,’ or ‘PrEP’ for short. According to the American Center for Disease Control and Prevention, the drug is reported to reduce the risk of contracting HIV by up to 90% when taken daily.

PrEP is intended for people who are at high risk of contracting HIV. This includes individuals whose current partner is HIV-positive, as well intravenous drug users. It is a preventative measure that is readily available in some countries across the globe, and has been recommended by the World Health Organisation since 2015. It has been approved for usage by those at risk of contracting HIV in the United States, where depending on income it can be obtained for free, and France, where it was approved in November 2015 and introduced the following January.

However, the drug is not readily available in Ireland despite increasing concerns about rising HIV figures. According to Newstalk, 513 people were diagnosed HIV-positive in the country last year, a startling increase of 5.8% from previous recorded figures. Numerous factors have been suggested to explain such a jump in numbers: a failing sexual education system; dating apps like Tinder or Grindr; disconnect between LGBTQ+ individuals and the history of the virus. Whatever the reasons, it is clear that immediate action must be taken to combat the spread of disease.

To read the rest of this article please follow this link:  http://on.irishtimes.com/bKoj84s